Chromocell Therapeutics (CHRO) Institutional Ownership $0.62 +0.08 (+14.84%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for Chromocell Therapeutics (NYSE:CHRO)CurrentInstitutional OwnershipPercentage77.96%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$659.95KNumber ofInstitutional Sellers(last 12 months)0 Get CHRO Insider Trade Alerts Want to know when executives and insiders are buying or selling Chromocell Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Chromocell Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/14/2024 Anson Funds Management LP251,888$660K0.0%N/A4.284% (Data available from 1/1/2016 forward) CHRO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CHRO shares? During the previous two years, the following institutional investors and hedge funds held shares of Chromocell Therapeutics shares: Anson Funds Management LP ($660K).Learn more on CHRO's institutional investors. What percentage of Chromocell Therapeutics stock is owned by institutional investors? 77.96% of Chromocell Therapeutics stock is owned by institutional investors. Learn more on CHRO's institutional investor holdings. Which institutional investors have been buying Chromocell Therapeutics stock? The following institutional investors have purchased Chromocell Therapeutics stock in the last 24 months: Anson Funds Management LP ($251.89K). How much institutional buying is happening at Chromocell Therapeutics? Institutional investors have bought a total of 251,888 shares in the last 24 months. This purchase volume represents approximately $659.95K in transactions. Related Companies Kazia Therapeutics Institutional Ownership Minerva Neurosciences Institutional Ownership NRx Pharmaceuticals Institutional Ownership PharmaCyte Biotech Institutional Ownership AIM ImmunoTech Institutional Ownership NLS Pharmaceutics Institutional Ownership Sensei Biotherapeutics Institutional Ownership Sol-Gel Technologies Institutional Ownership Talphera Institutional Ownership Aspira Women's Health Institutional Ownership This page (NYSE:CHRO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chromocell Therapeutics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chromocell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CHRO with Qtrade Free CHRO Stock Alerts